Labcorp Declares Quarterly Dividend
Labcorp (NYSE:LH), a leading global laboratory services provider, has announced a quarterly cash dividend of $0.72 per share of common stock. The dividend will be paid on September 11, 2025, to shareholders of record as of August 28, 2025.
Labcorp (NYSE:LH), un importante fornitore globale di servizi di laboratorio, ha annunciato un dividendo trimestrale in contanti di 0,72 $ per azione di azioni ordinarie. Il dividendo sar脿 pagato il 11 settembre 2025 agli azionisti registrati al 28 agosto 2025.
Labcorp (NYSE:LH), un proveedor global l铆der de servicios de laboratorio, ha anunciado un dividendo trimestral en efectivo de 0,72 $ por acci贸n de acciones ordinarias. El dividendo se pagar谩 el 11 de septiembre de 2025 a los accionistas registrados al 28 de agosto de 2025.
Labcorp (NYSE:LH), 靹戈硠鞝侅澑 靹犽弰 鞁ろ棙鞁� 靹滊箘鞀� 鞝滉车鞐呾泊臧 氤错喌欤� 1欤茧嫻 0.72雼煬鞚� 攵勱赴 順勱笀 氚半嫻旮堨潉 氚滍憸頄堨姷雼堧嫟. 氚半嫻旮堨潃 2025雲� 9鞗� 11鞚�鞐�, 2025雲� 8鞗� 28鞚� 旮办 欤检< 氇呺秬鞐� 霌膘灛霅� 欤检<霌れ棎瓴� 歆旮夒悹 鞓堨爼鞛呺媹雼�.
Labcorp (NYSE:LH), un fournisseur mondial de services de laboratoire de premier plan, a annonc茅 un dividende trimestriel en esp猫ces de 0,72 $ par action d鈥檃ctions ordinaires. Le dividende sera vers茅 le 11 septembre 2025 aux actionnaires inscrits au registre au 28 ao没t 2025.
Labcorp (NYSE:LH), ein f眉hrender globaler Anbieter von Labordienstleistungen, hat eine viertelj盲hrliche Bardividende von 0,72 $ pro Aktie der Stammaktien angek眉ndigt. Die Dividende wird am 11. September 2025 an die Aktion盲re ausgezahlt, die am 28. August 2025 im Aktienregister eingetragen sind.
- Regular dividend payment demonstrates financial stability and commitment to shareholder returns
- Consistent cash return to shareholders through quarterly dividend payments
- None.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than
View original content to download multimedia:
SOURCE Labcorp Holdings Inc